Met Life Investment Management, LLC Procept Bio Robotics Corp Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 24,536 shares of PRCT stock, worth $2.18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,536
Previous 24,536
-0.0%
Holding current value
$2.18 Million
Previous $1.5 Million
31.17%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding PRCT
# of Institutions
265Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$431 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$310 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$136 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$111 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$105 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.97B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...